ACS Editors' Choice: Natural Products as Sources of New Drugs — and More! - ACS Axial | ACS Publications

ACS Editors’ Choice: Natural Products as Sources of New Drugs — and More!

This week: Natural products as sources of new drugs — and more!

Each and every day, ACS grants free access to a new peer-reviewed research article from one of the Society’s journals. These articles are specially chosen by a team of scientific editors of ACS journals from around the world to highlight the transformative power of chemistry. Access to these articles will remain open to all as a public service.

Check out this week’s picks!
A Pictorial View of Viscosity in Ionic Liquids and the Link to Nanostructural Heterogeneity

J. Phys. Chem. Lett. 2020, 11, XXX, 2062-2066
DOI: 10.1021/acs.jpclett.0c00170
Heart-on-a-Chip Model with Integrated Extra- and Intracellular Bioelectronics for Monitoring Cardiac Electrophysiology under Acute Hypoxia

Nano Lett. 2020, XXXX, XXX, XXX-XXX
DOI: 10.1021/acs.nanolett.0c00076
Rheological Properties of Covalent Adaptable Networks with 1,2,3-Triazolium Cross-Links: The Missing Link between Vitrimers and Dissociative Networks

Macromolecules 2020, XXXX, XXX, XXX-XXX
DOI: 10.1021/acs.macromol.9b02204
Development of Indium-Tin Oxide Diffusion Barrier for Attaining High Reliability of Skutterudite Modules

ACS Appl. Energy Mater. 2020, XXXX, XXX, XXX-XXX
DOI: 10.1021/acsaem.0c00100
Local Structure in U(IV) and U(V) Environments: The Case of U3O7

Inorg. Chem. 2020, XXXX, XXX, XXX-XXX
DOI: 10.1021/acs.inorgchem.9b03702
Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019

J. Nat. Prod. 2020, XXXX, XXX, XXX-XXX
DOI: 10.1021/acs.jnatprod.9b01285
Molecular Nanomachines Can Destroy Tissue or Kill Multicellular Eukaryotes

ACS Appl. Mater. Interfaces 2020, XXXX, XXX, XXX-XXX
DOI: 10.1021/acsami.9b22595
Love ACS Editors’ Choice? Get a weekly e-mail of the latest ACS Editor’s Choice articles and never miss a breakthrough!

Want more stories like this delivered to your inbox?

Sign up for our newsletter to receive a selection of stories related to your favorite topics.

  • This field is for validation purposes and should be left unchanged.